Calix [CALX] vs Amdocs [DOX] Detailed Stock Comparison
Calix
NYSE
Loading...
Amdocs
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Calix wins in 4 metrics, Amdocs wins in 14 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Calix | Amdocs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,310.33 | 18.68 | Amdocs |
| Price-to-Book Ratio | 4.80 | 2.81 | Amdocs |
| Debt-to-Equity Ratio | 0.77 | 23.65 | Calix |
| PEG Ratio | 83.50 | 12.65 | Amdocs |
| EV/EBITDA | -199.00 | 9.96 | Calix |
| Profit Margin (TTM) | -3.09% | 11.94% | Amdocs |
| Operating Margin (TTM) | 0.16% | 17.69% | Amdocs |
| EBITDA Margin (TTM) | 0.16% | 17.69% | Amdocs |
| Return on Equity | -3.52% | 15.73% | Amdocs |
| Return on Assets (TTM) | -2.40% | 7.87% | Amdocs |
| Free Cash Flow (TTM) | $50.35M | $618.93M | Amdocs |
| 1-Year Return | 50.78% | 7.05% | Calix |
| Price-to-Sales Ratio (TTM) | 4.27 | 2.13 | Amdocs |
| Enterprise Value | $3.41B | $9.89B | Amdocs |
| EV/Revenue Ratio | 3.93 | 2.13 | Amdocs |
| Gross Profit Margin (TTM) | 56.35% | 38.13% | Calix |
| Revenue per Share (TTM) | $13 | $41 | Amdocs |
| Earnings per Share (Diluted) | $-0.41 | $4.76 | Amdocs |
| Beta (Stock Volatility) | 1.28 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Calix vs Amdocs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Calix | -0.16% | -0.02% | 6.14% | 34.54% | 37.94% | 67.20% |
| Amdocs | 0.63% | 4.11% | -3.21% | -0.53% | 3.37% | 5.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Calix | 50.78% | -0.16% | 170.03% | 615.66% | 453.52% | 316.15% |
| Amdocs | 7.05% | -0.09% | 43.80% | 47.11% | 238.94% | 195.94% |
Performance & Financial Health Analysis: Calix vs Amdocs
| Metric | CALX | DOX |
|---|---|---|
| Market Information | ||
| Market Cap | $3.71B | $9.89B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 686,180 | 697,190 |
| 90 Day Avg. Volume | 809,553 | 727,940 |
| Last Close | $56.59 | $89.43 |
| 52 Week Range | $28.61 - $57.98 | $78.61 - $95.41 |
| % from 52W High | -2.40% | -6.27% |
| All-Time High | $80.95 (Dec 27, 2021) | $99.75 (Jun 26, 2023) |
| % from All-Time High | -30.09% | -10.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | -0.08% |
| Quarterly Earnings Growth | 0.22% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.12% |
| Operating Margin (TTM) | 0.00% | 0.18% |
| Return on Equity (TTM) | -0.04% | 0.16% |
| Debt to Equity (MRQ) | 0.77 | 23.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.83 | $31.67 |
| Cash per Share (MRQ) | $4.58 | $3.10 |
| Operating Cash Flow (TTM) | $87.96M | $737.18M |
| Levered Free Cash Flow (TTM) | $100.81M | $560.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Calix vs Amdocs
| Metric | CALX | DOX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,310.33 | 18.68 |
| Forward P/E | 83.50 | 12.65 |
| PEG Ratio | 83.50 | 12.65 |
| Price to Sales (TTM) | 4.27 | 2.13 |
| Price to Book (MRQ) | 4.80 | 2.81 |
| Market Capitalization | ||
| Market Capitalization | $3.71B | $9.89B |
| Enterprise Value | $3.41B | $9.89B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.93 | 2.13 |
| Enterprise to EBITDA | -199.00 | 9.96 |
| Risk & Other Metrics | ||
| Beta | 1.28 | N/A |
| Book Value per Share (MRQ) | $11.83 | $31.67 |
Financial Statements Comparison: Calix vs Amdocs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CALX | DOX |
|---|---|---|
| Revenue/Sales | $220.24M | $1.13B |
| Cost of Goods Sold | $97.53M | $698.05M |
| Gross Profit | $122.71M | $430.15M |
| Research & Development | $43.98M | $81.80M |
| Operating Income (EBIT) | $-6.08M | $197.74M |
| EBITDA | $-1.81M | $244.14M |
| Pre-Tax Income | $-2.99M | $189.27M |
| Income Tax | $1.80M | $25.27M |
| Net Income (Profit) | $-4.79M | $164.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CALX | DOX |
|---|---|---|
| Cash & Equivalents | $42.30M | $247.39M |
| Total Current Assets | $562.00M | $1.56B |
| Total Current Liabilities | $122.82M | $1.34B |
| Long-Term Debt | $3.38M | $748.93M |
| Total Shareholders Equity | $767.17M | $3.50B |
| Retained Earnings | $-394.91M | N/A |
| Property, Plant & Equipment | $59.70M | $874.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CALX | DOX |
|---|---|---|
| Operating Cash Flow | $29.63M | $195.07M |
| Capital Expenditures | $-4.31M | $-15.96M |
| Free Cash Flow | $12.90M | $156.49M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-39.97M | $-135.24M |
Short Interest & Institutional Ownership Analysis
| Metric | CALX | DOX |
|---|---|---|
| Shares Short | 2.88M | 3.93M |
| Short Ratio | 4.47 | 5.04 |
| Short % of Float | 0.07% | 0.04% |
| Average Daily Volume (10 Day) | 686,180 | 697,190 |
| Average Daily Volume (90 Day) | 809,553 | 727,940 |
| Shares Outstanding | 66.43M | 112.89M |
| Float Shares | 58.71M | 108.54M |
| % Held by Insiders | 0.10% | 0.00% |
| % Held by Institutions | 0.88% | 1.00% |
Dividend Analysis & Yield Comparison: Calix vs Amdocs
| Metric | CALX | DOX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |